MedPath

Efficacy of Nd-YAG Laser with Verapamil in Peyronie’s Disease

Not Applicable
Conditions
Peyronie’s Disease.
Induratio penis plastica
Registration Number
IRCT201710088146N27
Lead Sponsor
Vice chancellor for research,Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
80
Inclusion Criteria

Inclusion Criteria: All Patients with Peyronie's Disease; aged 18 years and over; have at least Peyronie's Disease for 6 months ; Exclusion criteria: Patients with a Peyronie's Disease and receive multiple treatments; Skin disorder in the penis; History of Inflammatory diseases of the skin; uncontrolled hypertension; history of heart attacks in the last one month; patients with acute phase or released fibrosis plaque during the penis; patients who are not satisfied to entering the study;

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plaque size. Timepoint: One month and three months after the end of treatment. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath